Cargando…
When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial?
Autor principal: | Evans, Scott |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852589/ https://www.ncbi.nlm.nih.gov/pubmed/17443237 http://dx.doi.org/10.1371/journal.pctr.0020018 |
Ejemplares similares
-
When Clinical Trials Are Compromised: A Perspective from a Patient Advocate
por: Mayer, Musa
Publicado: (2005) -
When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
por: Brenner, Hermann, et al.
Publicado: (2023) -
The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research?
por: Hartmann, Markus, et al.
Publicado: (2006) -
The Failure of Environmental Education (and How We Can Fix It)
por: Blumstein, Daniel T, et al.
Publicado: (2007) -
How accurately can we assess zoonotic risk?
por: Wille, Michelle, et al.
Publicado: (2021)